1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Cell Line Development Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Cell Line Development Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Cell Line Development Market Regional Analysis
6.2 Europe Cell Line Development Market Revenue 2017-2027 (US$ Million)
6.3 Europe Cell Line Development Market Forecast Analysis
7. Europe Cell Line Development Market Analysis – by Type
7.1 Primary Cell Line
- 7.1.1 Overview
- 7.1.2 Primary Cell Line: Europe Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Hybridomas
- 7.2.1 Overview
- 7.2.2 Hybridomas: Europe Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Continuous Cell Lines
- 7.3.1 Overview
- 7.3.2 Continuous Cell Lines: Europe Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Recombinant Cell Line
- 7.4.1 Overview
- 7.4.2 Recombinant Cell Line: Europe Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Cell Line Development Market Analysis – by Product
8.1 Equipment and Media & Reagent
- 8.1.1 Overview
- 8.1.2 Equipment and Media & Reagent: Europe Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Cell Line Development Market Analysis – by Application
9.1 Drug Discovery
- 9.1.1 Overview
- 9.1.2 Drug Discovery: Europe Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Bioproduction and Tissue Engineering
- 9.2.1 Overview
- 9.2.2 Bioproduction and Tissue Engineering: Europe Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Europe Cell Line Development Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Cell Line Development Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 Europe Cell Line Development Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 UK: Europe Cell Line Development Market Breakdown, by Type
- 10.2.1.1.2 UK: Europe Cell Line Development Market Breakdown, by Product
- 10.2.1.1.3 UK: Europe Cell Line Development Market Breakdown, by Application
- 10.2.1.2 Germany:
Europe Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Germany: Europe Cell Line Development Market Breakdown, by Type
- 10.2.1.2.2 Germany: Europe Cell Line Development Market Breakdown, by Product
- 10.2.1.2.3 Germany: Europe Cell Line Development Market Breakdown, by Application
- 10.2.1.3 France:
Europe Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 France: Europe Cell Line Development Market Breakdown, by Type
- 10.2.1.3.2 France: Europe Cell Line Development Market Breakdown, by Product
- 10.2.1.3.3 France: Europe Cell Line Development Market Breakdown, by Application
- 10.2.1.4 Russia:
Europe Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.4.1 Russia: Europe Cell Line Development Market Breakdown, by Type
- 10.2.1.4.2 Russia: Europe Cell Line Development Market Breakdown, by Product
- 10.2.1.4.3 Russia: Europe Cell Line Development Market Breakdown, by Application
- 10.2.1.5 Italy:
Europe Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.5.1 Italy: Europe Cell Line Development Market Breakdown, by Type
- 10.2.1.5.2 Italy: Europe Cell Line Development Market Breakdown, by Product
- 10.2.1.5.3 Italy: Europe Cell Line Development Market Breakdown, by Application
- 10.2.1.6 Rest of Europe:
Europe Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Cell Line Development Market Breakdown, by Type
- 10.2.1.6.2 Rest of Europe: Europe Cell Line Development Market Breakdown, by Product
- 10.2.1.6.3 Rest of Europe: Europe Cell Line Development Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Merck KGaA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 SELEXIS
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 WuXiAppTec
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 General Electric
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Lonza
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Corning Incorporated
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe Cell Line Development Market
